Form D/A — NGM Bio Holdings, Inc.
0001231919-26-000278 · filed Mar 27, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $142,039,949
- Reported amount sold
- $142,039,949
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- NGM Bio Holdings, Inc.
- CIK
- 2029767
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2024
- Address
- 611 Gateway Blvd., Suite 540
SOUTH SAN FRANCISCO, CA 94080 - Phone
- 650-243-5555
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Roger M. Perlmutter · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Peter Svennilson · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Diana Peng Bockus · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
Tim Kutzkey · DirectorSouth San Francisco, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗